Visiting the same primary care physician may delay cancer diagnosis
the ONA take:
According to a recent study published in the British Journal of General Practice, a team led by researchers at the University of Bristol in the United Kingdom has found that patients who consulted an unknown doctor tended to have their lung and colorectal cancer symptoms picked up more quickly compared with those who saw their usual general practitioner.
However, the study also showed that those who followed-up with the same health care provider about new symptoms led a to quicker diagnosis.
The study found that seeing the same doctor over the 2 years prior to diagnosis was associated with a 7 day delay to diagnosis for colorectal cancer.
Those who saw the same doctor after cancer symptoms were spotted received a diagnosis about 14 days quicker for colorectal cancer and 18 days quicker for lung cancer compared to those who saw a different doctor.
"These findings provide some evidence that GPs should follow up patients who present with potential cancer symptoms to make sure they receive a timely diagnosis. Interestingly, we also found that your regular doctor might not be the best person to spot those symptoms in the first place. So in some cases getting a second opinion from a different doctor could speed up the time to diagnosis," said study leader Matthew Ridd, MB, ChB, DRCOG, MRCGP.
Patients who consulted an unknown doctor tended to have their lung and colorectal cancer symptoms picked up more quickly.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|